Segments - Aortic Valve Market by Valve Type (Mechanical and Biological), Suture Type (Suture and Sutureless), Surgery Type (Minimally Invasive Surgery and Open Surgery), End-user (Hospitals and Ambulatory Surgery Centers), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2024–2032
The global aortic valve market size was USD 11.7 Billion in 2023 and is projected to reach USD 34.5 Billion by 2032, expanding at a CAGR of 14.5% during 2024–2032. The market growth is attributed to the rising healthcare expenditure in emerging economies.
Growing prevalence of heart-related conditions leads to a high demand for aortic valve interventions, which is anticipated to boost the market in the coming years. Advances in medical technology, such as minimally invasive procedures and the development of innovative valve replacement technologies, impact the market significantly.
Increasing incidences of aortic valve diseases, such as aortic stenosis, and the rising awareness among the population about early diagnosis of heart-related diseases propels the market. Moreover, economic factors and rising healthcare expenditures in different regions influence the adoption of advanced medical technologies, including aortic valve interventions.
AI-powered imaging tools help detect aortic valve diseases early and accurately, as these tools analyze medical images, such as echocardiograms and MRI, to identify aortic stenosis or other valve conditions. Early diagnosis leads to enhanced patient outcomes.
AI enhances the precision and accuracy of robot-assisted aortic valve surgeries. AI-powered robotic systems assist surgeons in performing complex procedures with high precision and control.
Key players in the aortic valve market are investing in AI tools and technologies to enhance their product offerings and gain a competitive edge. Furthermore, they are integrating AI tools into their product offerings and developing advanced technologies.
Rising favorable regulatory environments and reimbursement policies in healthcare increase the accessibility and adoption of aortic valve interventions, thereby driving the market. Timely approvals and supportive reimbursement policies encourage healthcare providers to offer these procedures. Furthermore, rising awareness of cardiovascular health and advancements in diagnostic tools contribute to early detection of aortic valve diseases. Early diagnosis increases the chances of intervention and drives the demand for aortic valve treatments.
Safety concerns in aortic valve interventions hinder the market. Medical procedures often include potential risks and complications. Concerns about adverse events, postoperative complications, or long-term outcomes deter both patients and physicians from decision-making. Thus, some patients choose alternative treatment options, such as medications, that are less invasive and cost-effective.
Growing investments in healthcare infrastructure, particularly in developing countries, increase access to aortic valve interventions, thereby creating immense opportunities in the market. The capability to diagnose and treat aortic valve diseases increases, as the healthcare system develops. The research and development activities in the field of cardiovascular medicine led to the discovery of new treatment modalities, improved devices, and enhanced procedural techniques. Thus, R&D investments contribute to the increasing treatment options, thus fueling the market.
The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics are included in the report.
Attributes |
Details |
Report Title |
Aortic Valve Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2023 |
Historic Data |
2017 -2022 |
Forecast Period |
2024–2032 |
Segmentation |
Valve Type (Mechanical and Biological), Suture Type (Suture and Sutureless), Surgery Type (Minimally Invasive Surgery and Open Surgery), and End-user (Hospitals and Ambulatory Surgery Centers) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast |
Key Players Covered in the Report |
American Heart Association; American College of Cardiology; European Society of Cardiology; European Heart Network; International Diabetes Federation; International Diabetes Federation; National Center for Biotechnology Information; Organization for Economic Co-operation and Development; United Nations Department of Economic and Social Affairs; and World Health Organization |
Based on valve type, the aortic valve market is bifurcated into mechanical and biological.
The mechanical segment is expected to dominate the market in terms of revenue generation during the forecast period, as it is the most common type of valve used in aortic valve replacement procedures. It is made up of plastic or metal and has a longer life than tissue valves. Mechanical valves are typically made from durable materials, such as metal or carbon, as they have a longer lifespan compared to biological valves.
Mechanical valve provides good hemodynamic performance, allowing for efficient blood flow through the heart chambers. They are often compatible with various imaging techniques, such as echocardiography or magnetic resonance imaging, allowing for accurate monitoring of valve function and potential complications over time.
The biological segment is projected to hold a large market share during the projected period, as they are often made from animal tissue or human tissue. They do not require long-term anticoagulant therapy, which is advantageous for certain patient populations.
Rising geriatric population boosts the demand for heart valve replacement procedures. However, biological valves are often preferred for elderly patients with health concerns that make lifelong anticoagulant therapy less desirable. Biological valves often provide enhanced hemodynamic performance, allowing for smooth blood flow throughout the heart chambers.
On the basis of suture type, the aortic valve market is categorized into suture and sutureless.
The suture segment held a major share of the market in 2023. Various suture types are used in aortic valve surgeries that vary depending on factors such as surgical techniques, surgeon preference, and the specific type of valve being implanted. The surgery typically begins with the creation of an incision in the chest to access the heart. The specific type and location of incision vary depending on factors such as the anatomy of patients and the surgical approach chosen by the surgeon.
The sutureless segment is anticipated to grow at a significant pace during the forecast period, as it is an innovative approach aimed at simplifying and expediting the process of aortic valve replacement. Sutureless techniques typically require less time to implant the replacement valve compared to traditional suture methods, potentially reducing the duration of the surgical procedure. Sutureless procedures reduce the time the aorta is clamped during surgery, which reduces the risk of complications such as stroke and kidney injury.
The anchoring mechanism used in sutureless valves is designed to securely position the replacement valve in the correct anatomical location, potentially reducing the risk of valve dislodgement or migration.
Based on surgery type, the aortic valve market is segmented into minimally invasive surgery and open surgery.
The minimally invasive surgery segment is estimated to expand at a CAGR of 16.2% during the assessment period due to the growing awareness among the population about the benefits of minimally invasive surgery. MIS has several potential benefits over traditional open surgery, such as small incision, which results in less pain, bleeding, and scarring.
Several types of minimally invasive surgery include laparoscopic surgery, robotic surgery, thoracoscopic surgery, and endoscopic surgery. These surgeries are suitable for all types of patients. Furthermore, reduced risk of infection, hospital stays, and recovery time associated with MIS boost the segment.
The open surgery segment is expected to expand at a CAGR of 6.1% during the projection period. Open surgery has been the standard approach for years and remains a common method for aortic valve replacement, particularly in cases where patients are not suitable candidates for less invasive procedures. This method involves stopping the heart temporarily and using a heart-lung bypass machine to maintain blood circulation during the surgery. The cost-effectiveness of this surgery contributes to segmental growth.
On the basis of end-user, the aortic valve market is divided into hospitals and ambulatory surgery centers.
The hospitals segment is projected to hold a significant market share during the forecast period, as hospitals are typically the primary providers of healthcare services. The majority of heart-related surgeries, including aortic valve replacement and heart valve replacement, are performed in hospitals due to the availability of skilled workforces. Furthermore, enhanced care provided by hospitals makes them a preferred choice among patients to perform surgeries.
The ambulatory surgical centers segment is expected to grow at a rapid pace during the forecast period due to the growing number of transcatheter aortic valve replacement (TAVR) procedures in ambulatory surgical centers. TAVR is a minimally invasive procedure performed in outpatient settings, as it is less complex and requires a shorter recovery time compared to open surgery. The rising number of ambulatory surgical centers in developing as well as developed regions and the rising number of TVAR procedures in outpatient settings contribute to segmental growth.
In terms of region, the aortic valve market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa.
North America held a key share of the market in 2023 and is anticipated to dominate the market during the forecast period, as the region has been a hub for technological innovation in medical devices and procedures. The introduction and adoption of transcatheter aortic valve replacement (TAVR) and other minimally invasive techniques have played a crucial role in the market growth.
The presence of well-established healthcare systems and reimbursement policies in North America supports patient access to aortic valve interventions. Adequate reimbursement policies play a crucial role in the adoption of new technologies and procedures. Moreover, increasing investments in the healthcare sector are propelling the market in the region.
The market in Europe is projected to expand at a CAGR of 11.2% during the assessment period. The region is frequently chosen as a prime location for clinical trials and research in the healthcare sector. Ongoing research and development activities contribute to the introduction of new aortic valve treatments and improvements in existing technologies. Awareness about cardiovascular health and the availability of treatment options are generally high in Europe, thereby boosting the market.
The aortic valve market has been segmented on the basis of
Key players competing in the global aortic valve market are American Heart Association; American College of Cardiology; European Society of Cardiology; European Heart Network; International Diabetes Federation; International Diabetes Federation; National Center for Biotechnology Information; Organization for Economic Co-operation and Development; United Nations Department of Economic and Social Affairs; and World Health Organization.
These players utilize several development strategies, including product launches, partnerships, acquisitions, and geographical expansion, to increase their global presence. For instance,
In September 2019, Medtronic plc disclosed the FDA endorsement and introduction of the Evolut PRO+ TAVR system in the US. This system offers a reduced delivery profile and enhanced contact area between the valve and the native aortic annulus, aiming to enhance valve sealing effectiveness.